2018
DOI: 10.1177/1932296818798347
|View full text |Cite
|
Sign up to set email alerts
|

Noninvasive Monitoring of Blood Glucose Using Color-Coded Photoplethysmographic Images of the Illuminated Fingertip Within the Visible and Near-Infrared Range: Opportunities and Questions

Abstract: Noninvasive blood glucose assays have been promised for many years and various molecular spectroscopy-based methods of skin are candidates for achieving this goal. Due to the small spectral signatures of the glucose used for direct physical detection, moreover hidden among a largely variable background, broad spectral intervals are usually required to provide the mandatory analytical selectivity, but no such device has so far reached the accuracy that is required for self-monitoring of blood glucose (SMBG). A … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 25 publications
(9 citation statements)
references
References 41 publications
(63 reference statements)
0
9
0
Order By: Relevance
“…Global companies are developing other innovative medical devices as well, including non-invasive glucose meters. 30 31 Such bio-signal monitoring devices can be used for disease management and treatment in different hospital environments, such as intensive care unit, operating room, emergency room, and recovery room, in addition to being used for predicting and diagnosing diseases based on the accumulated real-time information. One prime example of this is the collaboration between Medtronic and IBM in developing Sugar.IQ by combining Medtronic's continuous glucose monitoring and IBM's AI Watson.…”
Section: Ai Application Areas In Health Carementioning
confidence: 99%
“…Global companies are developing other innovative medical devices as well, including non-invasive glucose meters. 30 31 Such bio-signal monitoring devices can be used for disease management and treatment in different hospital environments, such as intensive care unit, operating room, emergency room, and recovery room, in addition to being used for predicting and diagnosing diseases based on the accumulated real-time information. One prime example of this is the collaboration between Medtronic and IBM in developing Sugar.IQ by combining Medtronic's continuous glucose monitoring and IBM's AI Watson.…”
Section: Ai Application Areas In Health Carementioning
confidence: 99%
“…One of the shortcomings of this method is the inability to address interference that may come from other devices. Vahlsing et al [32] proposed a photoplethysmograph signal-based smart sensor method which obtains sensors from a device attached to a diabetes patient so that glucose level can be continuously monitored to maintain patient health status. The limitation of this method is that it doesn't show directly how glucose reading can be estimated but rather serve as a trial method.…”
Section: Smart Sensor Methodsmentioning
confidence: 99%
“…Still, spectroscopic signals originating from glucose molecules are weak, which challenges the signal-to-noise ratio (SNR) of the instrumentation. [16][17][18][19] Fundamentally, the SNR for the instrumentation must be sufficient to enable measurement of the weak signals from glucose over background noise and other sources of instrumental variation. In addition, the measurement signal must be selective relative to all other components of skin, including membranes, glycosylated structures, and soluble compounds within the ISF matrix, such as albumin, urea, amino acids, and ascorbic acid.…”
Section: Technological Approaches For Glucose Monitoring Productsmentioning
confidence: 99%